Back to News
Market Impact: 0.35

RxSight, Inc. Reports Third Quarter 2026 Financial Results

Source: Nasdaq

Corporate EarningsCompany Fundamentals

RxSight reported third-quarter 2026 revenue of $24.6 million, down 19% from the year-earlier period, primarily due to ongoing competitive pressures. The article’s available text ends before providing further detail on revenue recognized under its strategic collaboration with Alcon.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.35

Ticker Sentiment

RXST-0.60

More News

From AllMind Research

Browse all research